The US Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research (CDER) approved 50 new drug therapies in 2021. While the figure is a slight decrease from 2020, more drugs were ...
BeOne is an emerging Chinese biotechnology company with a global leading position in hematologic cancers, thanks to its core drug Brukinsa. Since its approval in 2019, Brukinsa’s stronger efficacy and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results